METASTATIC COLORECTAL CARCINOMA (MCRC)
Clinical trials for METASTATIC COLORECTAL CARCINOMA (MCRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CARCINOMA (MCRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CARCINOMA (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tegavivint tested in patients with advanced colorectal cancer
Disease control Recruiting nowThis study tests a new drug, tegavivint, in people with metastatic colorectal cancer that has worsened after at least two prior treatments. The goal is to find a safe dose and see if the drug, alone or with standard therapies, can shrink tumors. About 126 adults with specific gen…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Phase: PHASE1, PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 26, 2026 06:32 UTC
-
New blood test could reveal hidden cancer spread in colorectal patients
Diagnosis Recruiting nowThis study aims to develop a simple blood test that can detect whether colorectal cancer has spread beyond the liver to other parts of the body. Current imaging methods often miss small or hidden metastases, which can affect treatment choices. Researchers will analyze tiny partic…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 26, 2026 06:38 UTC
-
Could a common drug help cancer patients regain appetite and weight?
Symptom relief Recruiting nowThis study tests whether olanzapine, a drug that affects brain chemicals, can help people with advanced cancer who are losing weight and appetite. About 66 adults with certain cancers (like lung, stomach, or colon) will receive either olanzapine or a placebo. The goal is to see i…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated May 26, 2026 06:23 UTC